November 2026 is an important date to watch for telehealth providers across the U.S. The Drug Enforcement Administration (DEA) is moving toward a permanent framework for telemedicine prescribing, with a final rule expected that month.
With regulatory changes on the horizon, providers may also be reviewing their quality and compliance credentials. Several telehealth accreditations are recognized by health plans, but the most appropriate choice depends on the provider and its payer relationships.
Now is a good time to review those options alongside prescribing processes, patient safeguards, and quality systems.
What Is Changing With Telemedicine Prescribing in 2026?
A major change is moving closer to reality. On August 25, 2026, the DEA submitted its final rule on telemedicine prescribing of controlled substances to the White House Office of Management and Budget for a regulatory review.
The Department of Justice’s forecast points to November 2026 for final action. The rule was classified as economically significant, which applies to regulatory actions with an estimated annual economic effect of $100 million or more.
The proposed framework could create a special registration pathway for DEA-registered practitioners to prescribe controlled substances through telemedicine, including medications used to treat opioid use disorder and attention-deficit/hyperactivity disorder.
It would replace the temporary extensions that have allowed remote prescribing since pandemic-era flexibilities suspended the in-person examination requirement. The latest extension remains in place through December 31, 2026.
A permanent federal framework could also bring more consistency to telemedicine prescribing across state lines. This is crucial for providers serving patients across multiple states, as differing requirements can complicate virtual care and create barriers in areas with limited access to health services.
According to URAC, a nonprofit, independent healthcare accreditation organization with more than 30 years of experience, clearer federal direction could help address those challenges.
The organization says, “DEA’s national leadership is needed to set a clear path forward for the nation and to encourage more consistent definitions and aligned requirements from state regulatory bodies – to encourage care in our most underserved areas, without geographic barriers limiting access to care.”
The final rule could still change before publication, but its progress gives providers a reason to prepare now.
What Should Telehealth Providers Have in Place Before the Final Rule?
The scale of existing telehealth use makes regulatory preparation vital. The American Medical Association found that 71.4% of physicians used telehealth weekly in 2024, compared with 25.1% in 2018 and 79% in 2020.
As virtual care remains part of routine practice, providers can use the period before the DEA rule takes effect to examine whether their existing systems can accommodate changing requirements. These can include the following areas.
Controlled-Substance Prescription
Controlled-substance prescribing is one area that warrants close review. Organizations can map which medications are prescribed remotely, examine the rules supporting those decisions, and flag workflows that currently depend on temporary federal flexibilities.
Telehealth Documentation
The same attention should go to the patient record. Documentation needs to show what occurred during a virtual encounter, why a treatment or prescription was appropriate, and what follow-up was arranged. Patient consent should be captured when required as well.
State Licensure Requirements
View this post on Instagram
Licensure can become complicated when the patient and clinician are in different states. Providers generally need to comply with the licensing rules of the state where the patient is located, although some states offer limited exceptions, telehealth-specific licenses or interstate compacts.
Patient Data and Privacy
Privacy is another area that can be easy to overlook when reviewing clinical workflows in telemedicine.
In his discussion of telehealth practice standards, researcher Kyle Y. Faget says, “Given the myriad of laws and regulations applicable to data privacy and security that affect the telemedicine industry, it is important that telehealth providers address privacy and security proactively by taking such steps as developing privacy policies to ensure that patient data are adequately protected.”
Telehealth Accreditation
Telehealth accreditation should also be part of that foundation. An accreditation program can give providers an independent set of standards for assessing areas such as patient safety, quality, prescribing, documentation, and regulatory compliance.
These checks can strengthen the telehealth program regardless of the final DEA requirements.
Which Telehealth Accreditation Is the Most Recognized by Health Plans?
“Undertaking the accreditation process demonstrates your commitment to upholding and improving outcomes throughout the healthcare landscape,” URAC notes.
Thus, choosing an accreditation can be an important way to demonstrate a telehealth program’s commitment to quality and safety. However, there is no single telehealth accreditation that is universally recognized by all health plans. Recognition can vary by payer, provider type, services, and contracting requirements.
Several established organizations offer telehealth accreditation or certification:
- NCQA: Primarily known for accrediting health plans, NCQA also offers Virtual Care Accreditation for organizations providing virtual care.
- URAC: One of the first independent nonprofit organizations to develop telehealth accreditation, with standards covering clinical care, risk management, and more.
- The Joint Commission: The largest overall healthcare accreditor in the U.S., with a dedicated Telehealth Accreditation program and strong recognition among hospitals and health systems.
- ACHC: Offers telehealth certification for organizations, including smaller virtual care and remote patient monitoring providers.
For that reason, providers should check the accreditation preferences of their current and prospective health plans rather than assuming that a single credential carries the same weight everywhere. The scope of each program and its fit with the provider’s services also matter.
How Should Providers Choose a Telehealth Accreditation?
Accreditation can serve as more than a credential for a telehealth organization. In The Joint Commission Journal on Quality and Patient Safety, researchers Mahrokh M. Kobeissi and Joanne V. Hickey describe telehealth accreditation as “one method for ongoing improvement for organizations based on standards.”
That makes the choice of accreditor important, since the value lies in both the credential itself and whether the standards fit the organization’s goals.
That’s why the first consideration should be fit. Providers should look for standards designed specifically for virtual care and relevant to the services they offer.
An organization that prescribes medication remotely may need particular attention to prescribing and medication management. Patient safety, consent, privacy, technology, and clinical oversight may carry different weights depending on the care model.
It’s also vital to pay attention to payer recognition. Providers should find out which accreditations their existing and prospective health plans recognize or require. A credential is more useful when it supports actual contracting and network needs.
The process itself deserves consideration. Accreditation can require fees, staff time, documentation, interviews, reviews, and ongoing monitoring.
Research by Alhawajreh, Jackson and Paterson found that “Healthcare professionals agree that accreditation has improved the quality of healthcare services and hospitals’ performance” across clinical and administrative areas. That suggests the process can have value outside of meeting a payer requirement, provided the chosen standards genuinely support the organization’s quality goals.
Frequently Asked Questions
Find out the most commonly asked questions about telemedicine and the DEA’s final rule.
Before the Rule Drops
The DEA’s expected November 2026 rule makes now a sensible time for telehealth providers to review prescribing, documentation, licensure, privacy, and accreditation.
Preparing early can give organizations more time to address gaps and adapt when the permanent framework takes effect.
